Akers Biosciences Inc. (AKER)

[leifsmith]

I read somewhere that the surviving company will be MyMD Pharmaceuticals. My undependable recollection is that the Akers stockholders are getting 20%, and that Akers is providing $3MM in funding. All would need verification. I've seen no trace of Jonnie in the deal, except to the usual Johns Hopkins researchers with whom he's worked for years.